Abstract
Abstract Significance: Breast Cancers (BC) evolve and acquire adaptive changes while in active communication with the surrounding host normal tissue. Understanding how host tissue interacts with cancers during breast cancer progression could lead to novel biomarkers or targeted therapies. Innovation: We hypothesized that novel molecular subtypes of microenvironment (ME) can be identified and have prognostic value. Stromal signatures are poorly understood and the independent prognostic value of stroma and/or ME response has not been widely studied. Approach: We used gene expression data 1) to identify molecular subtypes of microenvironment, 2) to study the distribution and prevalence of microenvironment subtypes in an ethnically diverse group of BC cases and 3) to test the value of ME in predicting breast cancer progression. In 2009, our team initiated the UNC NORMAL BREAST STUDY (NBS), a unique epidemiologic study of normal tissue from ethnically diverse patients at UNC Hospitals. The NBS has recruited over 200 patients undergoing breast surgery at UNC Hospitals, including cosmetic surgeries, excisional diagnostic breast biopsies, lumpectomies and mastectomies. All participants donate snap frozen and paraffin-embedded normal breast tissue. For all patients who have been diagnosed with breast cancer, the gross distance between the tumor and the normal breast tissue specimen is measured. In addition all study participants are asked to submit a blood sample and complete a telephone interview regarding demographics and environmental exposures. Medical record abstraction is performed to obtain treatment data and anthropometry. Each sample is carefully analyzed for histopathology and whole genome gene expression data is collected. Results: Among the breast cancer patients profiled in our initial studies, unsupervised clustering resulted in two groups of patients, one of which showed expression features suggestive of an activated mesenchyme. We then generated an EMT signature using cell line models and observed that this signature is enriched in one cluster or subgroup of these patients. In the approximately 40% of patients where the EMT signature is enriched, survival was decreased, and survival was significantly decreased among patients with ER positive disease. Conclusion: The NBS allows a unique opportunity to make an impact in discovering novel biology of human breast cancer microenvironment. The information gained from this translational study will establish whether microenvironment subtypes are associated with recurrence risk and will elucidate how variation in host biology contributes to BC disparities. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 2213. doi:10.1158/1538-7445.AM2011-2213
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
